FI854171A0 - 1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL. - Google Patents
1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL.Info
- Publication number
- FI854171A0 FI854171A0 FI854171A FI854171A FI854171A0 FI 854171 A0 FI854171 A0 FI 854171A0 FI 854171 A FI854171 A FI 854171A FI 854171 A FI854171 A FI 854171A FI 854171 A0 FI854171 A0 FI 854171A0
- Authority
- FI
- Finland
- Prior art keywords
- phenyl
- group
- alkyl
- atoms
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1. Compounds of the general formula (I) see diagramm : EP0179386,P26,F3 in which R represents phenyl, pyridyl or the benzoxadiazolyl radical, the phenyl radical containing 1 or 2 identical or different substituents from the group comprising nitro, trifluoromethyl, fluorine, chlorine and cyano, R**1 and R**3 are identical of different and each represent alkyl with 1 to 4 carbon atoms, or one of the substituents R**1 or R**3 represents hydroxymethyl, amino or cyano, R**2 represents hydrogen or alkyl with 1 or 2 carbon atoms, A either represents an alkylene group which has up to 12 carbon atoms and is substituted by methyl, ethyl or propyl, and which is optionally substituted or interrupted by a phenyl group and/or is optionally interrupted by an oxygen or sulphur atom or a grouping of the formula -NR**6 , or A represents a straight-chain or branched alkylene group which has up to 12 carbon atoms and is optionally interrupted by an oxygen or sulphur atom or a grouping of the formula -NR**6 when a) R**4 represents phenyl, benzyl, CO-R**6 , CO2 -R**6' , CO-NR**6 R**7 , SO2 R6 or -CH2 -CHOH-CH2 -OR**8 , or b) R represents pyridyl or benzoxadiazolyl, or c) R**5 represents indolyl, or d) the alkylene chain is interrupted by a sulphur atom or the group -NR**6 or e) X represents COR**9 , wherein R**6 und R**7 are identical or different and each represent hydrogen, alkyl with up to 4 C atoms, benzyl or phenyl and wherein R**8 has the meaning given for R**5 and can be identical or different from this radical wherein R**9 represents alkyl which has 1 to 7 C atoms and is optionally substituted by halogen, cyano, alkoxy or dialkylamino with in each case 1-4 C atoms, or denotes phenyl, naphthyl, phenylalkyl or anilino or an amino, monoalkylamino or dialkylamino group with in each case 1 to 4 C atoms, the alkyl groups optionally forming, with the nitrogen atom a 5-membered to 7-membered ring which can contain an oxygen atom as a further hetero-atom and wherein R**6' has the meaning of R**6 , but does not denote hydrogen, R**4 represents hydrogen, or represents straight-chain or branched alkyl with 1 to 3 carbon atoms, or represents phenyl or benzyl, or represents a radical of the formula CO-R**6 , CO2 -R**6' , CO-NR**6 R**7 , SO2 -R**6 or -CH2 -CHOH-CH2 -OR**8 , wherein R**6 , R**6' , R**7 , R**8 und R**9 have the abovementioned meaning, R**5 represents phenyl, naphthyl or indolyl, the phenyl radical optionally being substituted by 1 or 2 identical or different substituents from the group comprising fluorine, chlorine, nitro, cyano, alkyl with 1 or 2 C atoms, NR**6 , R**7 , NR**6 COR**7 , the group CH2 -CO-NH2 or acetyl and X represents the group COOR**10 , wherein R**10 represents a straight-chain, branched or cyclic alkyl radical which has up to 12 C atoms and is optionally interrupted in the chain by an oxygen atom and/or is optionally substituted by fluorine, chlorine, hydroxyl, pyridyl, phenyl or amino, or represents the group COR**9 , wherein R**9 has the abovementioned meaning, and pharmaceutically acceptable acid addition salts thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66490484A | 1984-10-26 | 1984-10-26 | |
US76918185A | 1985-08-23 | 1985-08-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI854171A0 true FI854171A0 (en) | 1985-10-24 |
FI854171L FI854171L (en) | 1986-04-27 |
Family
ID=27099086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI854171A FI854171L (en) | 1984-10-26 | 1985-10-24 | 1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0179386B1 (en) |
KR (1) | KR860003222A (en) |
CN (1) | CN85107866A (en) |
AT (1) | ATE43838T1 (en) |
AU (1) | AU4909785A (en) |
DE (1) | DE3570874D1 (en) |
DK (1) | DK491285A (en) |
ES (1) | ES8701725A1 (en) |
FI (1) | FI854171L (en) |
GR (1) | GR852569B (en) |
HU (1) | HU194543B (en) |
IL (1) | IL76800A0 (en) |
NO (1) | NO854021L (en) |
PT (1) | PT81366B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60156671A (en) * | 1984-01-25 | 1985-08-16 | Yamanouchi Pharmaceut Co Ltd | Dihydropyridine derivative and its preparation |
GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
JPS6112662A (en) * | 1984-06-28 | 1986-01-21 | Yamanouchi Pharmaceut Co Ltd | Dihydropyridine derivative and its production |
EP0254682A1 (en) * | 1986-07-22 | 1988-01-27 | Ciba-Geigy Ag | Phenoxyaliphatylphenylenoxyalkylesters and -amides |
WO1989008644A1 (en) * | 1988-03-11 | 1989-09-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New 1-phenylpropyl compounds |
DE3833893A1 (en) * | 1988-10-05 | 1990-04-12 | Bayer Ag | USE OF BASIC NITRO-PHENYL-DIHYDROPYRIDINE AMIDES AS A MEDICINAL PRODUCT, NEW COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF NEW INTERMEDIATE PRODUCTS |
DE3833894A1 (en) * | 1988-10-05 | 1990-04-12 | Bayer Ag | BASIC DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS INTERMEDIATE PRODUCTS |
GB9102031D0 (en) * | 1991-01-30 | 1991-03-13 | Fujisawa Pharmaceutical Co | Dihydropyridine compounds,and process for their preparation |
AU4586093A (en) * | 1992-07-28 | 1994-02-14 | Daicel Chemical Industries Ltd. | Antihypertensive 1,4-dihydropyridine derivatives and process for their preparation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
DE2753946A1 (en) * | 1977-12-03 | 1979-06-13 | Bayer Ag | 1-N-ARYL-1,4-DIHYDROPYRIDINE AND THEIR USE AS A MEDICINAL PRODUCT |
DE3208628A1 (en) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
JPS60156671A (en) * | 1984-01-25 | 1985-08-16 | Yamanouchi Pharmaceut Co Ltd | Dihydropyridine derivative and its preparation |
US4994476A (en) * | 1984-10-31 | 1991-02-19 | Bristol-Myers Company | Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties |
-
1985
- 1985-10-10 NO NO854021A patent/NO854021L/en unknown
- 1985-10-15 AT AT85113060T patent/ATE43838T1/en not_active IP Right Cessation
- 1985-10-15 DE DE8585113060T patent/DE3570874D1/en not_active Expired
- 1985-10-15 EP EP85113060A patent/EP0179386B1/en not_active Expired
- 1985-10-23 IL IL76800A patent/IL76800A0/en unknown
- 1985-10-24 FI FI854171A patent/FI854171L/en not_active Application Discontinuation
- 1985-10-24 PT PT81366A patent/PT81366B/en unknown
- 1985-10-24 ES ES548187A patent/ES8701725A1/en not_active Expired
- 1985-10-24 GR GR852569A patent/GR852569B/el unknown
- 1985-10-25 AU AU49097/85A patent/AU4909785A/en not_active Abandoned
- 1985-10-25 HU HU854116A patent/HU194543B/en unknown
- 1985-10-25 DK DK491285A patent/DK491285A/en not_active Application Discontinuation
- 1985-10-26 KR KR1019850007923A patent/KR860003222A/en not_active Application Discontinuation
- 1985-10-26 CN CN198585107866A patent/CN85107866A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ATE43838T1 (en) | 1989-06-15 |
EP0179386A3 (en) | 1987-08-05 |
AU4909785A (en) | 1986-05-01 |
DE3570874D1 (en) | 1989-07-13 |
GR852569B (en) | 1986-02-25 |
HU194543B (en) | 1988-02-29 |
ES548187A0 (en) | 1986-12-01 |
NO854021L (en) | 1986-04-28 |
PT81366A (en) | 1985-11-01 |
KR860003222A (en) | 1986-05-21 |
CN85107866A (en) | 1986-07-30 |
DK491285A (en) | 1986-04-27 |
DK491285D0 (en) | 1985-10-25 |
ES8701725A1 (en) | 1986-12-01 |
EP0179386A2 (en) | 1986-04-30 |
HUT40080A (en) | 1986-11-28 |
PT81366B (en) | 1987-08-05 |
FI854171L (en) | 1986-04-27 |
IL76800A0 (en) | 1986-02-28 |
EP0179386B1 (en) | 1989-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE50987T1 (en) | DIHYDROPYRIDE DERIVATIVES, THEIR PREPARATION AND USE. | |
ES524236A0 (en) | A PROCEDURE FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE | |
FI854171A0 (en) | 1,4-DIHYDROPYRIDINE-HYDROXIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAOVAEL SOM DERAS ANVAENDNING SOM LAEKEMEDEL. | |
DK452687A (en) | DIHYDROPYRIDINE COMPOUNDS, ISOMERS, ISOMER MIXTURES, OPTICAL ANTIPODES AND RACEMATES THEREOF, THEIR PREPARATION AND USE AS MEDICINES | |
DE68905407D1 (en) | ANALGETIC CARBONIC ACID DERIVATIVES. | |
DK492283D0 (en) | PROCEDURE FOR THE PREPARATION OF NAPHTALEND DERIVATIVES | |
ES527739A0 (en) | A PROCEDURE FOR PREPARING PIRIMIDINE DERIVATIVES | |
ATE38675T1 (en) | PHOSPHATE ESTER DERIVATIVES AND THEIR USE AS AN ANTI-CANCER AGENT. | |
DE3650373D1 (en) | Morpholine derivatives, processes for their preparation and their use as fungicides. | |
DK6880A (en) | 4-AMINOPRYRIDINES PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES | |
DK352081A (en) | METHOD FOR PREPARING 3- (N-ARYLAMINO) -TETRAHYDROTHIOPHEN2-ON DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |
Owner name: BAYER AKTIENGESELLSCHAFT |